Inappin en es it fr

Inappin Brand names, Inappin Analogs

Inappin Brand Names Mixture

  • No information avaliable

Inappin Chemical_Formula


Inappin RX_link

Inappin fda sheet

Inappin msds (material safety sheet)

Inappin MSDS

Inappin Synthesis Reference

No information avaliable

Inappin Molecular Weight

166.24 g/mol

Inappin Melting Point

No information avaliable

Inappin H2O Solubility

Appreciable as liquid hydrochloride salt

Inappin State


Inappin LogP


Inappin Dosage Forms

Liquid for injection

Inappin Indication

For the differential diagnosis of myasthenia gravis and as an adjunct in the evaluation of treatment requirements in this disease. It may also be used for evaluating emergency treatment in myasthenic crises.

Inappin Pharmacology

Edrophonium is a short and rapid-acting anticholinesterase drug. Its effect is manifest within 30 to 60 seconds after injection and lasts an average of 10 minutes. Edrophonium's pharmacologic action is due primarily to the inhibition or inactivation of acetylcholinesterase at sites of cholinergic transmission. Muscarinic receptors are found throughout the body, especially on muscle. Stimulation of these receptors causes to muscle contraction. In myasthenia gravis the body's immune system destroys many of the muscarinic receptors, so that the muscle becomes less responsive to nervous stimulation. Edrophonium chloride increases the amount of acetylcholine at the nerve endings. Increased levels of acetyl choline allow the remaining receptors to function more efficiently.

Inappin Absorption

Rapidly absorbed.

Inappin side effects and Toxicity

With drugs of this type, muscarine-like symptoms (nausea, vomiting, diarrhea, sweating, increased bronchial and salivary secretions and bradycardia) often appear with overdosage (cholinergic crisis).

Inappin Patient Information

No information avaliable

Inappin Organisms Affected

Humans and other mammals